ClinicalThought

Share

Program Content

Activities

  • CLL 1L Therapy
    Key Considerations in Selecting Frontline Therapy for Patients With CLL/SLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 24, 2024

    Expires: April 23, 2025

  • CLL/SLL: 2L Therapy
    Key Considerations in Selecting Second-line Therapy for Patients With CLL/SLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 15, 2024

    Expires: May 14, 2025

  • Treatment Tools in CLL
    The Value of Interactive Tools in Selecting Treatment for CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 28, 2024

    Expires: October 27, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AbbVie Inc.; AstraZeneca; Beigene, Ltd.; and Bristol Myers Squibb.

AbbVie Inc.

AstraZeneca

BeiGene, Ltd.

Bristol Myers Squibb

Partners

CLL Society

ProCE Banner